AI assistant
BIO-TECHNE Corp — Director's Dealing 2025
Aug 19, 2025
30718_dirs_2025-08-19_e57a4bbf-b3f7-4840-8607-1fc2d955c30f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-08-15
Reporting Person: Geist William (PRESIDENT, PROTEIN SCIENCES)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | Common Stock | M | 2623 | — | Acquired | 15915 | Direct |
| 2025-08-15 | Common Stock | F | 803 | $53.60 | Disposed | 15112 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | Restricted Stock Units | $ | M | 2623 | Disposed | Common Stock (2623) | Direct | |
| 2025-08-15 | Performance Restricted Stock Units | $ | A | 19355 | Acquired | Common Stock (19355) | Direct | |
| 2025-08-15 | Restricted Stock Units | $ | A | 9678 | Acquired | Common Stock (9678) | Direct | |
| 2025-08-15 | Stock Options (Right to Buy) | $53.60 | A | 24758 | Acquired | 2035-08-15 | Common Stock (24758) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $100.39 | 2029-02-01 | Common Stock (15912) | 15912 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (29600) | 29600 | Direct |
| Performance Restricted Stock Units | $ | Common Stock (9074) | 9074 | Direct | |
| Performance Stock Options (Right to Buy) | $84.61 | Common Stock (24424) | 24424 | Direct | |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (30059) | 30059 | Direct |
| Restricted Stock Units | $ | Common Stock (9911) | 9911 | Direct | |
| Performance Restricted Stock Units | $ | Common Stock (15738) | 15738 | Direct | |
| Stock Options (Right to Buy) | $74.91 | 2034-08-15 | Common Stock (21204) | 21204 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.
F3: Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F4: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
F6: 9,911 restricted stock units vest on 11/1/2025.
F7: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: 2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
F9: Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F10: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
F12: Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.